Lorenzo Piergallini1, Maxime Tardieu2, Federico Cagnazzo3, Grégory Gascou3, Cyril Dargazanli3, Imad Derraz3, Vincent Costalat3, Alain Bonafé3, Pierre-Henri Lefevre4. 1. Department of Interventional and Diagnostic Neuroradiology, Montpellier University Hospital, Montpellier, France; Postgraduation School of Radiodiagnostics, Università degli Studi di Milano, Milan, Italy. 2. Department of Radiology, Perpignan Hospital, Perpignan, France. 3. Department of Interventional and Diagnostic Neuroradiology, Montpellier University Hospital, Montpellier, France. 4. Department of Interventional and Diagnostic Neuroradiology, Montpellier University Hospital, Montpellier, France. Electronic address: ph.lefevre30@gmail.com.
Abstract
OBJECTIVE: To retrospectively review the outcome of patients with dural arteriovenous fistula of the anterior cranial fossa (afDAVF) treated by transarterial embolization. MATERIAL AND METHODS: Six consecutive patients were referred to our hospital for afDAVF treatment. After a multidisciplinary discussion, they underwent endovascular embolization with Onyx injection through the ophthalmic artery. Their clinical presentation, management and outcomes were retrospectively assessed. RESULTS: All interventions were performed with the liquid embolic agent Onyx through the transarterial route from the ophthalmic artery to access the fistulous point. All patients showed a good outcome with complete afDAVF obliteration. CONCLUSION: This study demonstrates that afDAVFs can be safely and completely obliterated by transarterial embolization via the ophthalmic artery.
OBJECTIVE: To retrospectively review the outcome of patients with dural arteriovenous fistula of the anterior cranial fossa (afDAVF) treated by transarterial embolization. MATERIAL AND METHODS: Six consecutive patients were referred to our hospital for afDAVF treatment. After a multidisciplinary discussion, they underwent endovascular embolization with Onyx injection through the ophthalmic artery. Their clinical presentation, management and outcomes were retrospectively assessed. RESULTS: All interventions were performed with the liquid embolic agent Onyx through the transarterial route from the ophthalmic artery to access the fistulous point. All patients showed a good outcome with complete afDAVF obliteration. CONCLUSION: This study demonstrates that afDAVFs can be safely and completely obliterated by transarterial embolization via the ophthalmic artery.
Authors: Mohammed A Azab; Emma R Dioso; Matthew C Findlay; Jayson Nelson; Cameron A Rawanduzy; Philip Johansen; Brandon Lucke-Wold Journal: J Rare Dis Orphan Drugs Date: 2022-06-07
Authors: Vera A Mayercik; Eric S Sussman; Benjamin Pulli; Robert L Dodd; Huy M Do; Nicholas A Telischak; Michael P Marks; Gary K Steinberg; Steven D Chang; Jeremy J Heit Journal: Interv Neuroradiol Date: 2020-10-26 Impact factor: 1.764